| 1 |
33230949 | The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake. | 2021 Mar 3 |
3 |
| 2 |
33933805 | Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation. | 2021 Jul |
1 |
| 3 |
32377929 | L-Type amino acid transporter 1 as a target for drug delivery. | 2020 May 6 |
1 |
| 4 |
33367937 | Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB). | 2020 Dec 25 |
1 |
| 5 |
30189294 | L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles. | 2019 Jan |
1 |
| 6 |
30867591 | Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. | 2019 Apr |
1 |
| 7 |
30055889 | Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug. | 2018 Sep 15 |
1 |
| 8 |
28490336 | Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells). | 2017 May 10 |
1 |
| 9 |
27224648 | Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors. | 2016 |
1 |
| 10 |
20606323 | Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson's disease. | 2010 |
1 |
| 11 |
18656534 | Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. | 2008 Oct 2 |
1 |
| 12 |
15351512 | The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study. | 2004 Sep 17 |
1 |